Straumann Holding AG Other Non-Current Liabilities 2012-2021 | SAUHY

Straumann Holding AG other non-current liabilities from 2012 to 2021. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Straumann Holding AG other non-current liabilities for the quarter ending December 31, 2021 were $0.201B, a 29.11% increase year-over-year.
  • Straumann Holding AG other non-current liabilities for 2021 were $0.133B, a 85.16% decline from 2020.
  • Straumann Holding AG other non-current liabilities for 2020 were $0.899B, a 163.45% increase from 2019.
  • Straumann Holding AG other non-current liabilities for 2019 were $0.341B, a 258.79% increase from 2018.
Straumann Holding AG Annual Other Non-Current Liabilities
(Millions of US $)
2021 $133
2020 $899
2019 $341
2018 $95
2017 $118
2016 $40
2015 $38
2014 $44
2013 $65
2012 $25
2011 $19
Straumann Holding AG Quarterly Other Non-Current Liabilities
(Millions of US $)
2021-12-31 $201
2020-12-31 $977
2020-06-30 $687
2019-12-31 $410
2018-12-31 $156
2017-12-31 $168
2017-06-30 $150
2016-12-31 $87
2016-06-30 $96
2015-12-31 $84
2014-12-31 $85
2013-12-31 $65
2013-06-30 $47
2012-12-31 $25
2012-06-30 $20
2011-12-31 $19
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.515B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47